Parasitic Infection in Anemic Pregnant Women

• Status: Recruiting
• Trial end date: 2021-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

Women included between 18 and 45 years old, pregnant during their second or third trimester of pregnancy (calculated by a sure menstrual date and confirmed by a 1st trimesteric ultrasound) with hemoglobin level below 10.5 mg /dL.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Albendazole; Metronidazole

Criteria

Inclusion Criteria:

• pregnant during their second or third trimester of pregnancy (calculated by a sure menstrual date and confirmed by a 1st trimesteric ultrasound)

• hemoglobin level below 10.5 mg /dL

Exclusion Criteria:

• women with chronic diseases as diabetes, heart, renal, hepatic or endocrinological disorders

• women diagnosed with blood diseases as hemoglobinopathy or vascular diseases as vasculitis.

• Women with autoimmune diseases and those allergic to iron or antihelminsic treatment were also excluded